Status: current, Defined. Date: 30-Jun 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4410041000168113 | Gliclazide MR (Pharmacor) (gliclazide 30 mg) modified release tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4410051000168110 | Gliclazide MR (Pharmacor) 30 mg modified release tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Gliclazide MR (Pharmacor) 30 mg modified release tablet | Is a | Gliclazide MR (Pharmacor) | true | Inferred relationship | Some | ||
| Gliclazide MR (Pharmacor) 30 mg modified release tablet | Is a | gliclazide 30 mg modified release tablet | true | Inferred relationship | Some | ||
| Gliclazide MR (Pharmacor) 30 mg modified release tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Gliclazide MR (Pharmacor) 30 mg modified release tablet | has manufactured dose form | modified release tablet | true | Inferred relationship | Some | ||
| Gliclazide MR (Pharmacor) 30 mg modified release tablet | has Australian BoSS | gliclazide | true | Inferred relationship | Some | 33555105 | |
| Gliclazide MR (Pharmacor) 30 mg modified release tablet | has intended active ingredient | gliclazide | true | Inferred relationship | Some | 33555105 | |
| Gliclazide MR (Pharmacor) 30 mg modified release tablet | has unit of use | tablet | true | Inferred relationship | Some | 1007294024 |
Reference Sets
Description inactivation indicator reference set
Trade product unit of use reference set
FHIR